Kim M - Search Results

1

The therapeutic efficacy of adenoviral vectors for cancer gene therapy is limited by a low level of primary adenovirus receptors on tumour cells.

Kim M, Zinn KR, Barnett BG, Sumerel LA, Krasnykh V, Curiel DT, Douglas JT. Kim M, et al. Eur J Cancer. 2002 Sep;38(14):1917-26. doi: 10.1016/s0959-8049(02)00131-4. Eur J Cancer. 2002. PMID: 12204675

2

A system for the propagation of adenoviral vectors with genetically modified receptor specificities.

Douglas JT, Miller CR, Kim M, Dmitriev I, Mikheeva G, Krasnykh V, Curiel DT. Douglas JT, et al. Among authors: kim m. Nat Biotechnol. 1999 May;17(5):470-5. doi: 10.1038/8647. Nat Biotechnol. 1999. PMID: 10331807

3

Efficient oncolysis by a replicating adenovirus (ad) in vivo is critically dependent on tumor expression of primary ad receptors.

Douglas JT, Kim M, Sumerel LA, Carey DE, Curiel DT. Douglas JT, et al. Among authors: kim m. Cancer Res. 2001 Feb 1;61(3):813-7. Cancer Res. 2001. PMID: 11221860

4

The coxsackievirus and adenovirus receptor acts as a tumour suppressor in malignant glioma cells.

Kim M, Sumerel LA, Belousova N, Lyons GR, Carey DE, Krasnykh V, Douglas JT. Kim M, et al. Br J Cancer. 2003 May 6;88(9):1411-6. doi: 10.1038/sj.bjc.6600932. Br J Cancer. 2003. PMID: 12778071 Free PMC article.

5

Tissue inhibitor of metalloproteinases-2 improves antitumor efficacy of a replicating adenovirus in vivo.

Kim MH, Bodenstine TM, Sumerel LA, Rivera AA, Baker AH, Douglas JT. Kim MH, et al. Cancer Biol Ther. 2006 Dec;5(12):1647-53. doi: 10.4161/cbt.5.12.3374. Epub 2006 Dec 7. Cancer Biol Ther. 2006. PMID: 17106248 Free PMC article.

6

Optimization of methods to achieve mRNA-mediated transfection of tumor cells in vitro and in vivo employing cationic liposome vectors.

Lu D, Benjamin R, Kim M, Conry RM, Curiel DT. Lu D, et al. Among authors: kim m. Cancer Gene Ther. 1994 Dec;1(4):245-52. Cancer Gene Ther. 1994. PMID: 7627814

7

A novel gene therapy strategy for elimination of prostate carcinoma cells from human bone marrow.

Kim M, Wright M, Deshane J, Accavitti MA, Tilden A, Saleh M, Vaughan WP, Carabasi MH, Rogers MD, Hockett RD Jr, Grizzle WE, Curiel DT. Kim M, et al. Hum Gene Ther. 1997 Jan 20;8(2):157-70. doi: 10.1089/hum.1997.8.2-157. Hum Gene Ther. 1997. PMID: 9017419

8

An intracellular anti-erbB-2 single-chain antibody is specifically cytotoxic to human breast carcinoma cells overexpressing erbB-2.

Wright M, Grim J, Deshane J, Kim M, Strong TV, Siegal GP, Curiel DT. Wright M, et al. Among authors: kim m. Gene Ther. 1997 Apr;4(4):317-22. doi: 10.1038/sj.gt.3300372. Gene Ther. 1997. PMID: 9176517

9

Tetracycline-induced expression of an anti-c-Myb single-chain antibody and its inhibitory effect on proliferation of the human leukemia cell line K562.

Kasono K, Heike Y, Xiang J, Piché A, Kim HG, Kim M, Hagiwara M, Nawrath M, Moelling K, Curiel DT. Kasono K, et al. Among authors: kim hg, kim m. Cancer Gene Ther. 2000 Jan;7(1):151-9. doi: 10.1038/sj.cgt.7700117. Cancer Gene Ther. 2000. PMID: 10678368

10

Frequently asked questions on surrogate endpoints in oncology-opportunities, pitfalls, and the way forward.

Mittal A, Kim MS, Dunn S, Wright K, Gyawali B. Mittal A, et al. Among authors: kim ms. EClinicalMedicine. 2024 Sep 13;76:102824. doi: 10.1016/j.eclinm.2024.102824. eCollection 2024 Oct. EClinicalMedicine. 2024. PMID: 39764569 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50,778 results

Search Page

Filters